KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 85 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,160,000 | +501.0% | 105,664 | +396.0% | 0.01% | +400.0% |
| Q2 2017 | $193,000 | -73.4% | 21,302 | -62.3% | 0.00% | -66.7% |
| Q1 2017 | $726,000 | +276.2% | 56,527 | +175.8% | 0.00% | +200.0% |
| Q4 2016 | $193,000 | +28.7% | 20,496 | +33.3% | 0.00% | 0.0% |
| Q3 2016 | $150,000 | +4.9% | 15,372 | -27.7% | 0.00% | 0.0% |
| Q2 2016 | $143,000 | +4.4% | 21,258 | +38.3% | 0.00% | 0.0% |
| Q1 2016 | $137,000 | -32.8% | 15,372 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $204,000 | +29.9% | 15,372 | +3.1% | 0.00% | 0.0% |
| Q3 2015 | $157,000 | -61.3% | 14,905 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $406,000 | +22.3% | 14,905 | +37.3% | 0.00% | +100.0% |
| Q1 2015 | $332,000 | -14.4% | 10,859 | +4.9% | 0.00% | -50.0% |
| Q4 2014 | $388,000 | +7.5% | 10,355 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $361,000 | -18.3% | 10,345 | +8.9% | 0.00% | 0.0% |
| Q2 2014 | $442,000 | +41.7% | 9,498 | -5.9% | 0.00% | +100.0% |
| Q1 2014 | $312,000 | +6.8% | 10,095 | -20.7% | 0.00% | 0.0% |
| Q4 2013 | $292,000 | – | 12,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |